Literature DB >> 27829606

Late-Onset Pulmonary Fistula after Resection of Pulmonary Metastasis from Colorectal Cancer Following Perioperative Chemotherapy with Bevacizumab.

Ryu Kanzaki1, Yasushi Shintani1, Masayoshi Inoue2, Tomohiro Kawamura1, Soichiro Funaki1, Masato Minami1, Meinoshin Okumura1.   

Abstract

Chemotherapy with bevacizumab followed by surgery is now a viable treatment option for pulmonary metastasis from colorectal cancer (CRC). We herein report two cases of late-onset pulmonary fistula after resection of pulmonary metastasis from CRC following perioperative chemotherapy with bevacizumab. One patient suffered from a late-onset pulmonary fistula that occurred 3 months after pulmonary resection, which was treated with chest drainage and pleurodesis. The other patient suffered from a pulmonary fistula after three cycles of chemotherapy with bevacizumab after pulmonary resection, and underwent surgery to treat the fistula.

Entities:  

Keywords:  bevacizumab; colorectal cancer; pulmonary fistula; pulmonary metastasectomy

Mesh:

Substances:

Year:  2016        PMID: 27829606      PMCID: PMC5483862          DOI: 10.5761/atcs.cr.16-00117

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  9 in total

1.  Pneumothorax after bevacizumab-containing chemotherapy: a case report.

Authors:  Sheng-Hsiang Yang; Jen-Kou Lin; Wei-Shone Chen; Tzu-Chen Lin; Shung-Haur Yang; Jeng-Kai Jiang; Shih-Ching Chang; Yuan-Tzu Lan; Ta-Chung Chao; Chueh-Chuan Yen; Cheng-Hwai Tzeng; Hao-Wei Teng
Journal:  Jpn J Clin Oncol       Date:  2010-10-28       Impact factor: 3.019

2.  A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection.

Authors:  R Wong; D Cunningham; Y Barbachano; C Saffery; J Valle; T Hickish; S Mudan; G Brown; A Khan; A Wotherspoon; A S Strimpakos; J Thomas; S Compton; Y J Chua; I Chau
Journal:  Ann Oncol       Date:  2011-02-01       Impact factor: 32.976

3.  Use of free subcutaneous fat pad for reduction of intraoperative air leak in thoracoscopic pulmonary resection cases with lung cancer.

Authors:  Yasushi Shintani; Masayoshi Inoue; Tomoyuki Nakagiri; Meinoshin Okumura
Journal:  Eur J Cardiothorac Surg       Date:  2014-01-23       Impact factor: 4.191

4.  Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer.

Authors:  M S Gordon; K Margolin; M Talpaz; G W Sledge; E Holmgren; R Benjamin; S Stalter; S Shak; D Adelman
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

Review 5.  Incidence and management of bevacizumab-related toxicities in colorectal cancer.

Authors:  M Wasif Saif; Ranee Mehra
Journal:  Expert Opin Drug Saf       Date:  2006-07       Impact factor: 4.250

6.  [Three cases of resected pulmonary metastasis from colorectal cancer after preoperative chemotherapy].

Authors:  Ken Imaizumi; Haruya Koshiishi; Takuya Nakata; Takatoshi Matsuyama; Takayuki Hirano; Keisuke Okuno; Tetsuki Yoshimura; Hiroki Ebana; Norihiko Ikeda
Journal:  Gan To Kagaku Ryoho       Date:  2014-11

7.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

Review 8.  Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma.

Authors:  Masayoshi Inoue; Mitsunori Ohta; Keiji Iuchi; Akihide Matsumura; Kan Ideguchi; Tsutomu Yasumitsu; Katsuhiro Nakagawa; Kenjiro Fukuhara; Hajime Maeda; Shin-ichi Takeda; Masato Minami; Yuko Ohno; Hikaru Matsuda
Journal:  Ann Thorac Surg       Date:  2004-07       Impact factor: 4.330

9.  Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing.

Authors:  L F Brown; K T Yeo; B Berse; T K Yeo; D R Senger; H F Dvorak; L van de Water
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

  9 in total
  3 in total

Review 1.  Late-onset bronchopleural fistula after lobectomy and adjuvant chemotherapy for lung cancer: A case report and review of the literature.

Authors:  Chu Zhang; Yong Pan; Rui-Mei Zhang; Wen-Bin Wu; Dong Liu; Miao Zhang
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

2.  Tracheomediastinal Fistula Formation After Endobronchial Ultrasound Transbronchial Needle Aspiration While on Bevacizumab Treatment.

Authors:  Alejandra Castro-Varela; Sofia Molina; Horiana B Grosu
Journal:  Cureus       Date:  2021-03-30

3.  Increased genitourinary fistula rate after bevacizumab in recurrent cervical cancer patients initially treated with definitive radiochemotherapy and image-guided adaptive brachytherapy.

Authors:  Alina Sturdza; Sandra Hofmann; Marlene Kranawetter; Stephan Polterauer; Christoph Grimm; Michael Krainer; Christian Kirisits; Richard Pötter; Alexander Reinthaller; Richard Schwameis
Journal:  Strahlenther Onkol       Date:  2017-07-18       Impact factor: 3.621

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.